Biallelic fumarate hydratase (FH) inactivation, which is the initiating event of hereditary leiomyomatosis and renal cell cancer (HLRCC), also activates NRF2 (116). Here, NFE2L2 is linked to hereditary leiomyomatosis and renal cell cancer.